Vasa Denticity
- P/E
- 63.89
Key Fundamentals
SMEHealthcare Equipment & SuppliesHealthcarePrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 7.54%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹6.98
- Book Value
- ₹103.18
- Market Cap
- —
- P/E (TTM)
- 63.89
- P/B
- 4.32
- ROE
- 4.88%
- Dividend Yield
- 0.00%
- EBITDA
- ₹15.40 Cr
- 52W High
- ₹612.00
- 52W Low
- ₹322.50
- Day Range
- ₹435.00 – ₹449.00
- Volume
- 1,750
Peer Comparison
Healthcare › Medical Equipment › Medical Equipment & Supplies
| ₹1,381.80 | 123.38 | ₹15,607 Cr | 11.63 | 0.00% | 13.80% | 18.00% | ₹1,077 Cr | ₹125 Cr | |
| ₹1,586.80 | 51.04 | ₹15,325 Cr | 5.18 | 0.23% | 9.02% | 12.50% | ₹1,997 Cr | ₹313 Cr | |
| ₹25.23 | 66.39 | ₹1,611 Cr | 3.61 | 0.20% | 8.91% | 11.40% | ₹367 Cr | ₹24 Cr | |
| ₹311.10 | 148.85 | ₹1,603 Cr | 2.61 | 0.67% | 2.44% | 4.59% | ₹441 Cr | ₹11 Cr | |
| ₹527.15 | 24.98 | ₹1,243 Cr | 2.52 | 0.00% | 26.00% | 22.40% | ₹201 Cr | ₹34 Cr | |
| ₹188.71 | 33.64 | ₹1,017 Cr | 4.27 | 0.00% | 14.80% | 15.00% | ₹287 Cr | ₹31 Cr | |
| ₹608.10 | — | ₹868 Cr | 5.64 | 0.00% | 16.90% | 18.90% | — | — | |
| ₹445.95 | 63.89 | ₹779 Cr | 4.32 | 0.00% | 4.88% | 7.54% | ₹299 Cr | ₹12 Cr | |
| Median 8 companies | ₹486.55 | 63.89 | ₹1,423 Cr | 4.30 | 0.00% | 11.41% | 13.75% | ₹367 Cr | ₹31 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 46
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 20
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 61
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 91
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 38
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 42
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Debtor days have improved from 20.1 to 15.3 days.
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -0.54%
- Company has a low return on equity of 12.9% over last 3 years.
- Earnings include an other income of Rs.4.61 Cr.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 4 | 6 | 9 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bullish | 2 | 0 | 8 |
Oscillators
Bearish
Overall
Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 53.07
- Neutral
- MACD (12,26,9)
- 0.88
- Bearish
- SMA (50)
- 428.17
- Bullish
- SMA (200)
- 430.79
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +46.94% |
|---|---|
| 3Y | +30.60% |
| 1Y | +13.69% |
| TTM | +17.15% |
Net profit
| 5Y | Zero base |
|---|---|
| 3Y | +11.20% |
| 1Y | −35.29% |
| TTM | −26.89% |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Turned negative |
| 1Y | Outflow widened by ₹22 Cr |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +4.01 pp |
|---|---|
| 3Y | −4.12 pp |
| 1Y | −5.53 pp |
| TTM | −4.05 pp |
Revenue by year
| Mar 2020 | ₹30.00 Cr |
|---|---|
| Mar 2021 | ₹40.00 Cr |
| Mar 2022 | ₹77.00 Cr |
| Mar 2023 | ₹123 Cr |
| Mar 2024 | ₹170 Cr |
| Mar 2025 | ₹241 Cr |
| Mar 2026 | ₹274 Cr |
Net profit by year
| Mar 2020 | ₹0.00 Cr |
|---|---|
| Mar 2021 | ₹0.00 Cr |
| Mar 2022 | ₹5.00 Cr |
| Mar 2023 | ₹8.00 Cr |
| Mar 2024 | ₹15.00 Cr |
| Mar 2025 | ₹17.00 Cr |
| Mar 2026 | ₹11.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 35.56 | 40.71 | 36.8 | 57.02 | 53.54 | 59.39 | 62.83 | 72.8 | 60.02 | 72.72 | 71.47 | 72.41 | 82.17 |
| Expenses | 32.3 | 37.14 | 33.34 | 48.88 | 48.91 | 52.99 | 57.3 | 66.28 | 56.86 | 66.65 | 69.64 | 72.19 | 77.09 |
| Operating Profit | 3.26 | 3.57 | 3.46 | 8.14 | 4.63 | 6.4 | 5.53 | 6.52 | 3.16 | 6.07 | 1.83 | 0.22 | 5.08 |
| OPM % | 9.17% | 8.77% | 9.4% | 14.28% | 8.65% | 10.78% | 8.8% | 8.96% | 5.26% | 8.35% | 2.56% | 0.3% | 6.18% |
| Other Income | 0.14 | 1.16 | 0.29 | 0.46 | 0.32 | 0.97 | 0.45 | 0.19 | 0.98 | 0.66 | 0.93 | 2.08 | 0.94 |
| Interest | 0.03 | 0.02 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.02 | 0.01 |
| Depreciation | 0.22 | 0.23 | 0.27 | 0.28 | 0.37 | 0.28 | 0.5 | 0.56 | 0.27 | 0.34 | 0.56 | 0.61 | 0.7 |
| PBT | 3.15 | 4.48 | 3.47 | 8.31 | 4.58 | 7.09 | 5.48 | 6.15 | 3.87 | 6.39 | 2.1 | 1.67 | 5.31 |
| Tax % | 19.37% | 16.74% | 29.39% | 23.59% | 25.55% | 24.4% | 27.19% | 29.76% | 25.84% | 21.91% | 25.71% | 19.16% | 20.9% |
| Net Profit | 2.55 | 3.73 | 2.45 | 6.35 | 3.42 | 5.37 | 3.99 | 4.32 | 2.87 | 4.99 | 1.56 | 1.36 | 4.19 |
| EPS (₹) | 1.59 | 2.33 | 1.53 | 3.96 | 2.14 | 3.35 | 2.4 | 2.6 | 1.73 | 2.88 | 0.9 | 0.78 | 2.42 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 40 | 77 | 123 | 170 | 241 | 274 | 299 |
| Expenses | 30 | 40 | 71 | 113 | 151 | 218 | 263 | 286 |
| Operating Profit | 0 | 0 | 6 | 10 | 19 | 23 | 11 | 13 |
| OPM % | 0.8% | 1.2% | 7% | 8% | 11% | 10% | 4.2% | 4.4% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 2 | 5 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 |
| PBT | 0 | 0 | 5 | 10 | 19 | 23 | 14 | 15 |
| Tax % | 0% | 27% | 0% | 24% | 22% | 27% | 23% | — |
| Net Profit | 0 | 0 | 5 | 8 | 15 | 17 | 11 | 12 |
| EPS (₹) | 0.07 | 0.27 | 4.1 | 5.92 | 9.42 | 10.28 | 6.22 | 6.98 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.2 | 0.2 | 0.2 | 13 | 16 | 17 | 17 |
| Reserves | 0 | 0 | 6 | 3 | 52 | 116 | 157 |
| Borrowings | 1 | 2 | 3 | 1 | 0 | 0 | 0 |
| Other Liabilities | 4 | 4 | 10 | 11 | 17 | 17 | 21 |
| Total Liabilities | 5 | 7 | 19 | 28 | 86 | 150 | 196 |
| Fixed Assets | 0 | 0 | 1 | 2 | 2 | 15 | 22 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 5 | 1 |
| Investments | 0 | 0 | 0 | 0 | 12 | 44 | 45 |
| Other Assets | 4 | 6 | 18 | 26 | 70 | 86 | 128 |
| Total Assets | 5 | 7 | 19 | 28 | 86 | 150 | 196 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 1 | 0 | 0 | 2 | −11 | −5 | −27 |
| Investing | 0 | −1 | 0 | −1 | −22 | −42 | −4 |
| Financing | 0 | 1 | 1 | 0 | 36 | 47 | 30 |
| Net Cash Flow | 0 | 0 | 1 | 1 | 3 | 0 | −1 |
| Free Cash Flow | 0 | −1 | 0 | 0 | −14 | −23 | −31 |
| CFO/EBITDA | 348 | −84 | 9 | 40 | −35 | 6 | −201 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 10 | 7 | 6 | 3 | 24 | 21 | 15 |
| Inventory Days | 34 | 30 | 63 | 70 | 99 | 112 | 150 |
| Days Payable | 44 | 30 | 32 | 28 | 33 | 23 | 26 |
| Cash Conversion Cycle | 0 | 6 | 37 | 45 | 90 | 110 | 139 |
| Working Capital Days | −5 | −8 | 19 | 36 | 84 | 95 | 134 |
| ROCE % | — | 29% | 95% | 80% | 45% | 22% | 8% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vasa Denticity insights
58 extracted metrics across FY20–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · Jun 2026Transcript
- Q2 FY26 concall · Nov 2025Transcript PPT
- Q1 FY26 concall · Aug 2025PPT
- Q4 FY25 concall · May 2025Transcript PPT
- 4 Jun 2026
- 6 May 2026
- 27 Apr 2026
- 5 Feb 2026
- 7 Nov 2025
- 30 Sep 2026
- 29 Sep 2026
- 29 Sep 2026
Frequently Asked Questions about Vasa Denticity
What does Vasa Denticity Ltd do?
Where is Vasa Denticity Ltd (DENTALKART) listed?
Which sector does Vasa Denticity Ltd belong to?
What is the PE ratio of Vasa Denticity Ltd?
What is the 52-week high and low of Vasa Denticity Ltd?
What is the Return on Equity (ROE) of Vasa Denticity Ltd?
Company Information
Incorporated in 2016, Vasa Denticity Limited is in the business of marketing and distribution of a comprehensive portfolio of Dental Products.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DENTALKART.md for Vasa Denticity Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.